Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saroja Pharma Industries IndiaNSE:SAROJA +3.15%15 Gross Margin % is 9.58% as of Mar. 2025, which is at its 10-year median of 9.58. GuruFocus rates NSE:SAROJA with a GF Score™ of 15/100. The stock has 4 warning signs investors should review. Among 939 Drug Manufacturers companies, Saroja Pharma Industries India ranks worse than 96.06% on this metric.
Saroja Pharma Industries India (NSE:SAROJA) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Saroja Pharma Industries India had a gross margin of 9.58% for the quarter that ended in Mar. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Saroja Pharma Industries India Gross Margin % Related Terms
Saroja Pharma Industries India Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saroja Pharma Industries India Gross Margin % Chart
Saroja Pharma Industries India Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
Mar25
Gross Margin %
9.06
9.55
9.76
12.36
9.58
Saroja Pharma Industries India Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
Mar25
Gross Margin %
9.06
9.55
9.76
12.36
9.58
NSE:SAROJA vs ZTS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Saroja Pharma Industries India's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saroja Pharma Industries India Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Saroja Pharma Industries India's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Saroja Pharma Industries India's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Saroja Pharma Industries India (NSE:SAROJA) has a Gross Margin % of 9.58% as of Mar. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Saroja Pharma Industries India and its competitors. This is near median its historical median of 9.58. Over the past decade, Saroja Pharma Industries India's Gross Margin % has ranged from 9.06 to 12.36. According to the industry distribution chart, Saroja Pharma Industries India ranks #902 out of 939 companies in the Drug Manufacturers industry, placing it in the top 96.1%.
Is Saroja Pharma Industries India's Gross Margin % too high?
Saroja Pharma Industries India's current Gross Margin % of 9.58% is near median its 10-year median of 9.58. Over the past 10 years, this metric has ranged from a low of 9.06 to a high of 12.36. The Drug Manufacturers industry median Gross Margin % is 48.54. Saroja Pharma Industries India's value of 9.58% is 80.3% below this industry median. Based on the distribution chart, Saroja Pharma Industries India ranks #902 out of 939 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Saroja Pharma Industries India has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Saroja Pharma Industries India's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Saroja Pharma Industries India ranks #902 out of 939 companies for Gross Margin %. This places Saroja Pharma Industries India in the lower half of its industry. The industry median Gross Margin % is 48.54. Saroja Pharma Industries India's value of 9.58% is 80.3% below this benchmark. Historically, Saroja Pharma Industries India's own Gross Margin % has ranged from 9.06 to 12.36 over the past decade. While the company's 10-year median is 9.58 vs. the industry median of 48.54, Saroja Pharma Industries India has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 939 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saroja Pharma Industries India's current Gross Margin % of 9.58% is 80.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Saroja Pharma Industries India and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saroja Pharma Industries India's current Gross Margin % is 9.58%, which is near median its own 10-year median of 9.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saroja Pharma Industries India stock overvalued right now?
Saroja Pharma Industries India (NSE:SAROJA) has a current Gross Margin % of 9.58%. The current Gross Margin % is 9.58%, which is near median its 10-year median of 9.58 and 80.3% below the Drug Manufacturers industry median of 48.54. Saroja Pharma Industries India's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Saroja Pharma Industries India (NSE:SAROJA), the current Gross Margin % is 9.58% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Saroja Pharma Industries India Ltd is a company engaged in the pharmaceutical and healthcare sector. The company trades in pharmaceutical active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents used for pharmaceutical products, including human and veterinary medicines. The company has only one reportable business segment, which is pharma chemicals, such as thionyl chloride and pharmaceutical intermediates. Geographically, it operates in India, Asia Pacific, Europe, and other regions, with the majority of its revenue generated from India.
15GF Score
Get the complete analysis for NSE:SAROJA
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAROJA has been successfully added to your 
